Key result
Pediatric coronary artery bypass surgery utilizing internal thoracic arteries is reviewed as the gold-standard and most reliable treatment for coronary lesions due to Kawasaki disease.
Why the study?
Does pediatric coronary artery bypass surgery utilizing internal thoracic arteries improve survival, cardiac events, and graft patency in children with Kawasaki disease coronary involvements?
Does pediatric coronary artery bypass surgery utilizing internal thoracic arteries improve survival, cardiac events, and graft patency in children with Kawasaki disease coronary involvements?
Pediatric coronary artery bypass surgery using internal thoracic arteries is the gold-standard treatment for coronary lesions due to Kawasaki disease.
Supports ITA grafting as standard for post-KD pediatric lesions; leaves open need for prospective comparative trials.
Pediatric coronary artery bypass surgery gained wide acceptance with the introduction of internal thoracic arteries (ITAs) for bypass operations for post Kawasaki disease (KD) lesions. The technique is now established as the standard surgical choice, and its safety even in infancy, graft patency, growth potential, graft longevity and clinical efficacy have been well documented. In this article the author reviews the development of pediatric coronary bypass as the main indication for the treatment of coronary lesions due to KD. I believe that coronary revascularization surgery in pediatric population utilizing uni- or bilateral ITAs is the current gold-standard as the most reliable treatment, although percutaneous coronary intervention with or without a stent has been tried with vague long-term results in children.
No takes yet. Share an insight, caveat, or question.
Soichiro Kitamura (2016) conducted a review in Kawasaki disease coronary involvements. Pediatric coronary artery bypass surgery utilizing internal thoracic arteries vs. Percutaneous coronary intervention was evaluated. Pediatric coronary artery bypass surgery utilizing internal thoracic arteries is reviewed as the gold-standard and most reliable treatment for coronary lesions due to Kawasaki disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: